6505--ME/ New Pluvicto Theronastic Therapy Radiopharmaceuticals/STL(VA-26-00053903) 657-26-4-1642-0063

The VA Heartland Network Contracting Office (Leavenworth, KS) is conducting market research for a one‑year Blanket Purchase Agreement to supply the proprietary radiopharmaceutical agent Pluvicto to the St. Louis VA Medical Center. The requirement is classified under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and is anticipated to be set aside for Service‑Disabled Veteran‑Owned Small Businesses (SDVOSB) in accordance with Public Law 109‑461, Section 8127. If an adequate SDVOSB response is not received, the acquisition may be re‑sourced to an alternate set‑aside or a full‑and‑open competition. Interested firms must submit, no later than 15 April 2026, 3:00 PM CST, a capability statement and the following company data: name, address, point of contact (phone, fax, email), UEI, CAGE code, Tax ID, and small‑business classification (e.g., SDVOSB, 8(a), HUBZone, WOSB, etc.). All respondents must be active in SAM.gov and, if claiming SDVOSB status, must also be registered in the SBA VetCert registry. Submissions should be emailed to Michael Murphy (Michael.murphy7@va.gov) with “36C255‑26‑Q‑0334 PLUVICTO” in the subject line.

Notice ID

c474db674e28437c8228ed49c78be96f

Solicitation Number

36C25526Q0334

NAICS Code

325412

Classification Code

6505